Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

How to Get Arcalyst (Rilonacept) Covered by UnitedHealthcare in Florida: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Arcalyst Approved by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Arcalyst (rilonacept) with 12-month approvals based on FDA indications: CAPS, DIRA, or recurrent pericarditis. Submit PA forms via the provider portal with specialist notes, diagnosis confirmation (ICD-10 codes), and clinical documentation. If denied, you have 180
5 min read

Getting Somatuline Depot (Lanreotide) Covered by UnitedHealthcare in California: Complete Prior Authorization and Billing Guide

Answer Box: Your Path to Coverage Getting Somatuline Depot (lanreotide) covered by UnitedHealthcare in California requires prior authorization through OptumRx. Start with proper medical coding: ICD-10 E22.0 for acromegaly or appropriate NET codes, HCPCS J1930 (1 mg per unit), and correct NDCs. UnitedHealthcare often requires step therapy with octreotide
5 min read

How to Get Vitrakvi (Larotrectinib) Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Vitrakvi Coverage To get Vitrakvi (larotrectinib) covered by UnitedHealthcare in North Carolina: Submit prior authorization via OptumRx with validated NTRK gene fusion test results, oncologist medical necessity letter documenting metastatic/unresectable disease, and prior therapy history. If denied, file internal appeal within 180 days, then
4 min read

The Requirements Checklist to Get Advate (octocog alfa) Covered by UnitedHealthcare in Illinois: Complete PA and Appeal Guide

Answer Box: Getting Advate Covered by UnitedHealthcare in Illinois Advate (octocog alfa) requires prior authorization through UnitedHealthcare's OptumRx with step therapy requirements favoring preferred Factor VIII products. The fastest path to approval: 1) Submit complete PA with hemophilia A diagnosis (ICD-10: D66), inhibitor-negative status, and bleeding history via
5 min read

How to Get Ocrevus (Ocrelizumab) Covered by UnitedHealthcare in Florida: Complete Guide with Forms, Appeals, and Timelines

Answer Box: Getting Ocrevus Covered by UnitedHealthcare in Florida Yes, UnitedHealthcare covers Ocrevus (ocrelizumab) for multiple sclerosis, but requires prior authorization with specific documentation. Your neurologist submits the PA request through the UHC Provider Portal or by fax to 866-940-7328, including MS diagnosis confirmation, hepatitis B screening results, and evidence
6 min read

How to Get Cabometyx (Cabozantinib) Covered by UnitedHealthcare in Washington: Complete PA Guide with ICD-10 Codes and Appeals

Answer Box: Getting Cabometyx Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization (PA) for Cabometyx (cabozantinib tablets) through OptumRx for all FDA-approved cancer indications in Washington. Submit PA with confirmed diagnosis (ICD-10: C64 for RCC, C22.0 for HCC), prior therapy documentation, and RECIST imaging showing progression. If denied,
6 min read

Getting Mycapssa (Octreotide Oral) Approved by UnitedHealthcare in Georgia: Prior Authorization Guide and Appeals Process

Answer Box: How to Get Mycapssa Approved by UnitedHealthcare in Georgia UnitedHealthcare requires prior authorization for Mycapssa (oral octreotide) with step therapy mandating prior response to injectable octreotide or lanreotide. Submit your PA through OptumRx with acromegaly diagnosis (E22.0), documented injectable response, and medical necessity letter. If denied, you
5 min read

How to Get Kymriah (tisagenlecleucel) Covered by UnitedHealthcare in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Kymriah Covered by UnitedHealthcare in Virginia UnitedHealthcare covers Kymriah (tisagenlecleucel) under medical benefits as autologous stem cell therapy, requiring prior authorization through OptumHealth Transplant Solutions. For B-cell ALL (≤25 years) or relapsed/refractory DLBCL after ≥2 therapy lines, submit via the UHC Provider Portal with CD19+ confirmation,
6 min read